Simons Foundation Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2012
NCT01040221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

pregnenolone (1 trial)

Drugs in Phase 1 Trials (2)

arbaclofen (1 trial)

trichuris suis ova (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3